Vedolizumab to prevent postoperative recurrence of Crohn's disease (the REPREVIO RCT)
"Vedolizumab prevented postoperative recurrence of CD & should be considered as a prophylactic treatment in individuals with risk factors for recurrence."
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00317-0/abstract
#GastroSky #IBDSky
"Vedolizumab prevented postoperative recurrence of CD & should be considered as a prophylactic treatment in individuals with risk factors for recurrence."
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00317-0/abstract
#GastroSky #IBDSky
Comments